Efficacy of Erlotinib in Neoadjuvant Setting in Patients With Stage IIIA, N2-positive Non-Small Cell Lung Cancer
NCT01130753
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
43
Enrollment
OTHER
Sponsor class
Conditions
Lung Neoplasms
Erlotinib
Neoadjuvant Therapy
Interventions
DRUG:
Erlotinib
Sponsor
Samsung Medical Center